Alzheimer’s disease (AD), the most common cause of dementia, is a neurodegenerative disorder characterized by impairments in memory, cognition, behavior, and language (
1,
2). In 2024, approximately 6.9 million individuals in the United States were living with AD, affecting nearly 10.9% of adults aged 65 and older (
2). In Iran, the prevalence of AD was estimated at 2.3% in 2017 (
3). Among the early manifestations of AD, language impairment — particularly in the form of naming difficulties — has been identified as a prominent and progressive feature (
4,
5). Language disturbances may begin years before diagnosis (
6), encompassing issues such as word retrieval failure, impaired auditory and written comprehension, and empty speech (
7). Naming disorders are frequently assessed in patients with AD through confrontational picture-naming tasks, which test the semantic, lexical, and phonological components of language (
8). Patients with AD commonly struggle with naming and verbal fluency tasks, showing poorer performance compared to cognitively healthy individuals (
9). Levelt’s theory of language production identifies a multi-stage process — concept retrieval, lemma selection, morpho-phonological encoding, and production — each associated with activation in specific brain regions (
10). For instance, the lemma stage involves the middle temporal gyrus, while lexical selection activates posterior temporal and Wernicke’s areas, and phonetic encoding engages Broca’s area (
11). In patients with AD, damage at the lemma level is thought to impair access to lexical nodes, particularly in noun and verb naming (
12).
Although many studies have reported significant naming deficits in patients with AD compared to healthy controls (
6-
9,
13-
16), the majority focus exclusively on noun naming. Bowles et al. and Almor et al. are among the few that examined verb naming, revealing inconsistent results regarding which category is more impaired (
14,
17). Notably, Almor et al. found greater noun impairment but did not account for disease severity. Other studies, such as those by Shuttleworth and Huber, Williams et al., Lin et al., and Silagi et al., have consistently demonstrated significant performance differences across varying levels of AD severity when compared to healthy participants (
4,
15-
18). Based on the research, naming disorder is correlated with a more rapid progression of the illness (
19) and whole-brain atrophy (
20), further highlighting the diagnostic value of lexical retrieval measures in patients with AD (
21).